Abstract Background Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive interstitial lung disease. Multiple research has revealed that the extracellular matrix (ECM) may be associated with the development and prognosis of IPF, however, the underlying mechanisms remain incompletely understood. Methods We included GSE70866 dataset from the GEO database and established an ECM-related prognostic model utilizing LASSO, Random forest and Support vector machines algorithms. To compare immune cell infiltration levels between the high and low risk groups, we employed the ssGSEA algorithm. Enrichment analysis was conducted to explore pathway differences between the high-risk and low-risk groups. Finally, the model genes were validated us...
Idiopathic pulmonary fibrosis (IPF) is a progressive, fatal lung disease with limited treatment opti...
Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive lung disease affecting ~5 million p...
Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive lung disease affecting ~5 million p...
Background\ud The course of disease for patients with idiopathic pulmonary fibrosis (IPF) is highly ...
BACKGROUND: The course of disease for patients with idiopathic pulmonary fibrosis (IPF) is highly he...
Background: Most patients with idiopathic pulmonary fibrosis (IPF) have poor prognosis; Effective pr...
Summary A large number of fibroblast foci (FF) predict mortality in idiopathic pulmonary fibrosis (...
A large number of fibroblast foci (FF) predict mortality in idiopathic pulmonary fibrosis (IPF). Oth...
Background: The course of disease for patients with idiopathic pulmonary fibrosis (IPF) is highly he...
Background: Most patients with idiopathic pulmonary fibrosis (IPF) have poor prognosis; Effective pr...
Background: Idiopathic pulmonary fibrosis (IPF) is a life-threatening disease whose etiology remains...
Background: Idiopathic pulmonary fibrosis (IPF) is a life-threatening disease whose etiology remains...
BackgroundIdiopathic pulmonary fibrosis (IPF) is a chronic and progressive condition with an unfavor...
Idiopathic pulmonary fibrosis (IPF) is a progressive disease whose etiology remains unknown. The pur...
Background: Idiopathic pulmonary fibrosis (IPF) is a life-threatening disease whose etiology remains...
Idiopathic pulmonary fibrosis (IPF) is a progressive, fatal lung disease with limited treatment opti...
Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive lung disease affecting ~5 million p...
Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive lung disease affecting ~5 million p...
Background\ud The course of disease for patients with idiopathic pulmonary fibrosis (IPF) is highly ...
BACKGROUND: The course of disease for patients with idiopathic pulmonary fibrosis (IPF) is highly he...
Background: Most patients with idiopathic pulmonary fibrosis (IPF) have poor prognosis; Effective pr...
Summary A large number of fibroblast foci (FF) predict mortality in idiopathic pulmonary fibrosis (...
A large number of fibroblast foci (FF) predict mortality in idiopathic pulmonary fibrosis (IPF). Oth...
Background: The course of disease for patients with idiopathic pulmonary fibrosis (IPF) is highly he...
Background: Most patients with idiopathic pulmonary fibrosis (IPF) have poor prognosis; Effective pr...
Background: Idiopathic pulmonary fibrosis (IPF) is a life-threatening disease whose etiology remains...
Background: Idiopathic pulmonary fibrosis (IPF) is a life-threatening disease whose etiology remains...
BackgroundIdiopathic pulmonary fibrosis (IPF) is a chronic and progressive condition with an unfavor...
Idiopathic pulmonary fibrosis (IPF) is a progressive disease whose etiology remains unknown. The pur...
Background: Idiopathic pulmonary fibrosis (IPF) is a life-threatening disease whose etiology remains...
Idiopathic pulmonary fibrosis (IPF) is a progressive, fatal lung disease with limited treatment opti...
Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive lung disease affecting ~5 million p...
Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive lung disease affecting ~5 million p...